VMPL New Delhi [India] November 7 Medtronic a global leader in healthcare technology unveiled results from the Prospective ...

NeurAxis (NASDAQ:NRXS – Get Free Report) and Medtronic (NYSE:MDT – Get Free Report) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength ...

Here are five FDA alerts and recalls from 2024 for orthopedic and spine specialists to know: ...

Global Remote Patient Monitoring Market is estimated to be valued at $40B in 2023, expected to grow at CAGR of ~12% during the forecast period (2024 – 2030) ...

This growth is primarily driven by the rising prevalence of cardiovascular diseases (CVDs) worldwide, alongside continuous ...

Boston Scientific is resuming its "Avant Guard" study of pulse field ablation (PFA) as a first-line therapy for atrial ...

The American Heart Association is highlighting the importance of continuous care for individuals with congenital heart ...

Medtronic plc develops, manufactures ... and therapies to treat other non-exclusive diseases and conditions; and patient monitoring and airway management products. The Diabetes Operating Unit segment ...

England's NHS is testing an artificial pancreas for children with Type 1 diabetes, a device already available in India.

This article explores practical use cases for AR/VR, highlighting how these technologies are revolutionizing workflows, ...